(2R,5R)-2,5-HEXANEDIOL, 98%, 1g

3'-Amino-3'-deoxyadenosine, 97%, 1g

4-[(N-BOC-Amino)methyl]phenylboronic acid, 95.0%, 10g

2,5-Di(pyridin-4-yl)-1,3,4-thiadiazole, 95%, 5g

6,8-Dibromoimidazo[1,5-a]pyridine, 98%, 1g

1-(bromomethyl)-2-(2-fluorophenoxy)benzene, 1g

3-Carboxybenzeneboronic acid, 97.0%, 25g

Ácido fórmico, 45%, puro, 1L, envase de vidrio

3-ethyl 5-methyl 2-[(2-aminoethoxy)methylidene]-4-(2-chlorophenyl)-6-methyl-1,2,3,4-tetrahydropyridine-3,5-dicarboxylate, 97%, 10g

2-(3-BROMOPHENYL)-4-METHYLPENTANOIC ACID, 95.0%, 1g

3-Amino-2,5-dimethylbenzonitrile, 97.0%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid hydrochloride, 95.0%, 1g

3-[5-(2-Methylpropyl)-1,2,4-oxadiazol-3-yl]piperidine hydrochloride, 1g